| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business &Strat Officer | Senior Vice President
1 company
Delong Mark Jeffrey is a Chief Business &Strat Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 1,384 | $65.00 | $89,954.46 | -2.1% | -27.2% | -54.0% | |
| Jan 16, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 1,631 | $66.81 | $108,964.83 | -2.4% | -22.3% | -56.2% | |
| Oct 23, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 131 | $46.04 | $6,030.74 | -0.3% | +44.2% | -39.2% | |
| Aug 17, 2022 | APLS Apellis Pharmaceuticals, Inc. | Senior Vice President | Sale+OE | 5,000 | $69.50 | $347,500.00 | -14.6% | -32.1% | -55.0% | |
| Aug 11, 2022 | APLS Apellis Pharmaceuticals, Inc. | Senior Vice President | Sale+OE | 5,000 | $67.00 | $335,000.00 | -14.6% | -32.8% | -50.5% | |
| Aug 8, 2022 | APLS Apellis Pharmaceuticals, Inc. | Senior Vice President | Sale+OE | 5,000 | $64.50 | $322,500.00 | -14.6% | -23.6% | -61.3% | |
| Aug 4, 2022 | APLS Apellis Pharmaceuticals, Inc. | Senior Vice President | Sale+OE | 10,000 | $60.75 | $607,500.00 | -13.6% | -3.4% | -60.0% | |
| Jul 27, 2022 | APLS Apellis Pharmaceuticals, Inc. | Senior Vice President | Sale+OE | 5,000 | $57.00 | $285,000.00 | -14.6% | +4.2% | -44.1% | |
| Jul 19, 2022 | APLS Apellis Pharmaceuticals, Inc. | Senior Vice President | Sale+OE | 5,000 | $56.42 | $282,100.00 | -14.6% | +12.2% | -22.2% | |
| Jun 16, 2022 | APLS Apellis Pharmaceuticals, Inc. | Senior Vice President | Sale+OE | 10,000 | $41.79 | $417,850.00 | -25.5% | +55.5% | +108.2% |